Terapia Génica del Cáncer
TGC
University of Washington School of Medicine
Seattle, Estados UnidosUniversity of Washington School of Medicine-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2021
-
Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1/2 study
The Lancet Diabetes and Endocrinology, Vol. 9, Núm. 8, pp. 491-501